ClinConnect ClinConnect Logo
Search / Trial NCT06923800

Exercise Interventions and Dietary Advice in Fibromyalgia and IBS

Launched by AZIENDA OSPEDALIERA SPECIALIZZATA IN GASTROENTEROLOGIA SAVERIO DE BELLIS · Apr 4, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Exercise Aerobic Exercise Fibromyalgia Irritable Bowel Syndrome

ClinConnect Summary

This clinical trial is looking at how exercise and dietary advice can help people who have both Fibromyalgia (FM) and Irritable Bowel Syndrome (IBS). FM is a condition that causes widespread pain, fatigue, and sleep issues, while IBS affects the gut and can lead to stomach discomfort. The researchers want to see if physical activity and changes in diet can improve the symptoms of both conditions, which often occur together and share some common underlying issues.

To participate in this trial, individuals need to be between 30 and 65 years old, have a confirmed diagnosis of both FM and IBS, and have moderate to severe IBS symptoms. Participants should be healthy enough to stop any current treatments for their conditions temporarily. Those who join the study can expect to engage in various exercise programs and receive dietary guidance, with the aim of reducing their symptoms and improving their overall well-being. This trial is not yet recruiting participants, but it represents an important step in exploring non-drug treatments for these challenging conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Confirmed diagnosis of Irritable Bowel Syndrome (IBS) concomitant with Fibromyalgia (FM).Meeting the American College of Rheumatology (ACR) diagnostic criteria for FM and meeting the Rome III/IV diagnostic criteria for IBS.
  • Total score on the Irritable Bowel Syndrome Severity Scoring System (IBS-SSS) ≥ 125 (indicating moderate to severe IBS symptoms).
  • Men and women aged between 30 and 65 years.
  • Body Mass Index (BMI) between 18.5 and 29.9.
  • Exclusion Criteria:
  • Individuals with severe cardiac, hepatic, neurological, psychiatric disorders, or other gastrointestinal diseases.
  • Individuals unable to discontinue symptom management therapies and medications for FM/IBS.

About Azienda Ospedaliera Specializzata In Gastroenterologia Saverio De Bellis

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio De Bellis is a leading healthcare institution dedicated to advancing the field of gastroenterology through innovative clinical research and patient-centered care. Renowned for its specialized services and comprehensive treatment options, the hospital is committed to improving patient outcomes and enhancing the understanding of gastrointestinal disorders. With a focus on rigorous clinical trials, the institution collaborates with multidisciplinary teams to explore new therapies and diagnostic methods, ensuring that it remains at the forefront of gastroenterological advancements.

Locations

Castellana Grotte, Bari, Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported